Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganaxolone in drug-resistant partial-onset seizures
NCT01963208Phase 3Completed
- Sponsor
- Marinus Pharmaceuticals
- Start
- Oct 2013
- Primary completion
- May 2016
- Modality
- Allosteric Modulators
- Countries
- 6
01
Overview
A Phase 3 trial of ganaxolone in epilepsy, sponsored by Marinus Pharmaceuticals. Started Oct 2013; status: completed.
02
Drugs
ganaxolone
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01963208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01963208.